The global radiation dose management market is experiencing significant growth, driven by increasing awareness of patient safety, technological advancements, and regulatory guidelines. The radiation dose management market was valued at USD 751.4 million in 2024 and is expected to increase from USD 854.2 million in 2025 to USD 2,235.1 million by 2032, growing at a compound annual growth rate (CAGR) of 14.7% during the forecast period. North America led the market in 2024, capturing a 38.57% share.
Top Companies in the Market
- Bayer AG (Germany)
- Siemens Healthineers AG (Germany)
- FUJIFILM Corporation (Japan)
- GE Healthcare (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Bracco (Italy)
- Medsquare SAS (France)
Key Market Insights
- North Americadominated the global market with a share of 38.57% in 2024.
- Radiation dose managementinvolves minimizing and optimizing radiation exposure, particularly during interventional radiology and imaging procedures.This includes radiation dose recording software, regulatory compliance, real-time staff dose monitoring, and technology for dose reduction, such as interactive reconstruction software.
- The market growth is attributed to the increasing number of medical imaging procedures worldwide, rising awareness of risks associated with radiation, and the increasing demand for early detection of severe conditions.
- Strategic initiatives by key players are anticipated to boost market growth.For instance, in November 2023, Qaelum NV partnered with Philips to revolutionize radiation dose management in medical imaging, enhancing patient safety and optimizing healthcare workflows.
Key Industry Development
In September 2023, Qaelum NV partnered with I-MED Radiology Network to extend the reach of Qaelum's DOSE and FOQA in the ANZ region. This collaboration aims to enhance radiation dose management practices across Australia and New Zealand.
Market Drivers & Restraints